Atara Biotherapeutics, Inc. (ATRA)
4.16
-0.08
(-1.89%)
USD |
NASDAQ |
Feb 20, 11:48
Atara Biotherapeutics EPS Diluted (Quarterly) : -0.3172 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Pfizer Inc. | -0.2898 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| AbbVie, Inc. | 1.024 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.303M |
| Revenue (Quarterly) | 3.453M |
| Total Expenses (Quarterly) | 7.756M |
| Enterprise Value | 75.46M |
| Gross Profit Margin (Quarterly) | 96.67% |
| Profit Margin (Quarterly) | -124.6% |
| Earnings Yield | 52.70% |
| Operating Earnings Yield | 76.22% |
| Normalized Earnings Yield | 70.03 |